Journals / Turkish journal of nephrology (Online) / 2019 / Cilt: 28 - Sayı: 3

Do Hemodialysis Patients Aware of the Importance of Using Home Sphygmomanometer?

Pages
202–207
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The primary reason for the patients’ not buying a device is lack of information about the importanceof home blood pressure monitoring.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We investigated the prevalence of patients owning a home sphygmomanometer among patients on hemodialysis, the type of home sphygmomanometer, the factors that affect owning a device, and the frequency of home bloodpressure monitoring.Materials and Methods: The study involved 359 prevalent hemodialysis patients from five hemodialysis centers.
📊
Key Findings & Data:The datawere collected by means of a questionnaire.Results: A total of 272 (75.8%) patients owned a home sphygmomanometer.
💡
Conclusion & Impact:The primary reason for the patients’ not buying a device is lack of information about the importanceof home blood pressure monitoring.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: We investigated the prevalence of patients owning a home sphygmomanometer among patients on hemodialysis, the type of home sphygmomanometer, the factors that affect owning a device, and the frequency of home bloodpressure monitoring.Materials and Methods: The study involved 359 prevalent hemodialysis patients from five hemodialysis centers. The datawere collected by means of a questionnaire.Results: A total of 272 (75.8%) patients owned a home sphygmomanometer. Most of them have been using an automated upper-arm device. The presence of diabetes and a high education level were the independent variables that affectedowning of a home sphygmomanometer. Of the patients owning a home sphygmomanometer, 23.9% measured their bloodpressure every day, whereas 14.7% stated that they measured it rarely or never. Of the 87 patients not having a home sphygmomanometer, 59.8% reported no reason for not buying a device.Conclusion: A significant proportion of patients on hemodialysis owns a home sphygmomanometer, the majority of whichis an upper-arm device. The rate of owning the device is higher among patients with a higher education level and amongpatients with diabetes. The primary reason for the patients’ not buying a device is lack of information about the importanceof home blood pressure monitoring.

🔖

Cite This Article

ERDEM, E., KARATAŞ, A., ECDER, T. (2019). Do Hemodialysis Patients Aware of the Importance of Using Home Sphygmomanometer?. Turkish journal of nephrology (Online), Cilt: 28 - Sayı: 3, 202–207. https://ajindex.com/articles/374860

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 2003
  2. [CrossRef] 2. Ecder T, Utas C, Ates K, Bieber B, Robinson BM, Pisoni RL, et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS) in Turkey. Hemodial Int 2017
  3. [CrossRef] 3. Iseki K, Nakai S, Shinzato T, Morita O, Shinoda T, Kikuchi K, et al. Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan. Ther Apher Dial 2007
  4. [CrossRef] 4. Agarwal R. Blood pressure and mortality among hemodialysis patients. Hypertension 2010
  5. [CrossRef] 5. Sarafidis PA, Persu A, Agarwal R, Burnier M, de Leeuw P, Ferro CJ, et al. Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). Nephrol Dial Transplant 2017
  6. [CrossRef] 6. Parati G, Ochoa JE, Bilo G, Agarwal R, Covic A, Dekker FW, et al. Hypertension in Chronic Kidney Disease Part 1: Out-of-Office Blood Pressure Monitoring: Methods, Thresholds, and Patterns. Hypertension 2016
  7. [CrossRef] 7. Zoccali C, Tripepi R, Torino C, Tripepi G, Mallamaci F. Moderator’s view: Ambulatory blood pressure monitoring and home blood pressure for the prognosis, diagnosis and treatment of hypertension in dialysis patients. Nephrol Dial Transplant 2015
  8. [CrossRef] 8. Agarwal R. The controversies of diagnosing and treating hypertension among hemodialysis patients. Semin Dial 2012
  9. [CrossRef] 9. Agarwal R. Epidemiology of interdialytic ambulatory hypertension and the role of volume excess. Am J Nephrol 2011
  10. [CrossRef] 10. Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D, et al. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. J Cardiovasc Nurs 2008
  11. [CrossRef] 11. Akpolat T. Home sphygmomanometers: what should a nephrologist know? J Nephrol 2011
  12. [CrossRef] 12. Akpolat T, Arici M, Sengul S, Derici U, Ulusoy S, Erturk S, Erdem Y. Home sphygmomano